Standard

Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice. / Eggink, Hannah M.; Tambyrajah, Lauren L.; van den Berg, Rosa et al.

In: Journal of endocrinology, Vol. 236, No. 2, 2018, p. 85-97.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

Eggink, HM, Tambyrajah, LL, van den Berg, R, Mol, IM, van den Heuvel, JK, Koehorst, M, Groen, AK, Boelen, A, Kalsbeek, A, Romijn, JA, Rensen, PCN, Kooijman, S & Soeters, MR 2018, 'Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice', Journal of endocrinology, vol. 236, no. 2, pp. 85-97. https://doi.org/10.1530/JOE-17-0503

APA

Eggink, H. M., Tambyrajah, L. L., van den Berg, R., Mol, I. M., van den Heuvel, J. K., Koehorst, M., Groen, A. K., Boelen, A., Kalsbeek, A., Romijn, J. A., Rensen, P. C. N., Kooijman, S., & Soeters, M. R. (2018). Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice. Journal of endocrinology, 236(2), 85-97. https://doi.org/10.1530/JOE-17-0503

Vancouver

Eggink HM, Tambyrajah LL, van den Berg R, Mol IM, van den Heuvel JK, Koehorst M et al. Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice. Journal of endocrinology. 2018;236(2):85-97. Epub 2017. doi: 10.1530/JOE-17-0503

Author

Eggink, Hannah M. ; Tambyrajah, Lauren L. ; van den Berg, Rosa et al. / Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice. In: Journal of endocrinology. 2018 ; Vol. 236, No. 2. pp. 85-97.

BibTeX

@article{ede9e572c92049dca324568c1946125e,
title = "Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice",
abstract = "Bile acids can function in the postprandial state as circulating signaling molecules in the regulation of glucose and lipid metabolism via the transmembrane receptor TGR5 and nuclear receptor FXR. Both receptors are present in the central nervous system, but their function in the brain is unclear. Therefore, we investigated the effects of intracerebroventricular (i.c.v.) administration of taurolithocholate (tLCA), a strong TGR5 agonist, and GW4064, a synthetic FXR agonist, on energy metabolism. We determined the effects of chronic i.c.v. infusion of tLCA, GW4064, or vehicle on energy expenditure, body weight and composition as well as tissue specific fatty acid uptake in mice equipped with osmotic minipumps. We found that i.c.v. administration of tLCA (final concentration in cerebrospinal fluid: 1 mu M) increased fat oxidation (tLCA group: 0.083 +/- 0.006 vs control group: 0.036 +/- 0.023 kcal/h, F = 5.46, P = 0.04) and decreased fat mass (after 9 days of tLCA infusion: 1.35 +/- 0.13 vs controls: 1.96 +/- 0.23 g, P = 0.03). These changes were associated with enhanced uptake of triglyceride-derived fatty acids by brown adipose tissue and with browning of subcutaneous white adipose tissue. I.c.v. administration of GW4064 (final concentration in cerebrospinal fluid: 10 mu M) did not affect energy metabolism, body composition nor bile acid levels, negating a role of FXR in the central nervous system in metabolic control. In conclusion, bile acids such as tLCA may exert metabolic effects on fat metabolism via the brain",
author = "Eggink, {Hannah M.} and Tambyrajah, {Lauren L.} and {van den Berg}, Rosa and Mol, {Isabel M.} and {van den Heuvel}, {Jose K.} and Martijn Koehorst and Groen, {Albert K.} and Anita Boelen and Andries Kalsbeek and Romijn, {Johannes A.} and Rensen, {Patrick C. N.} and Sander Kooijman and Soeters, {Maarten R.}",
year = "2018",
doi = "10.1530/JOE-17-0503",
language = "English",
volume = "236",
pages = "85--97",
journal = "Journal of endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "2",

}

RIS

TY - JOUR

T1 - Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice

AU - Eggink, Hannah M.

AU - Tambyrajah, Lauren L.

AU - van den Berg, Rosa

AU - Mol, Isabel M.

AU - van den Heuvel, Jose K.

AU - Koehorst, Martijn

AU - Groen, Albert K.

AU - Boelen, Anita

AU - Kalsbeek, Andries

AU - Romijn, Johannes A.

AU - Rensen, Patrick C. N.

AU - Kooijman, Sander

AU - Soeters, Maarten R.

PY - 2018

Y1 - 2018

N2 - Bile acids can function in the postprandial state as circulating signaling molecules in the regulation of glucose and lipid metabolism via the transmembrane receptor TGR5 and nuclear receptor FXR. Both receptors are present in the central nervous system, but their function in the brain is unclear. Therefore, we investigated the effects of intracerebroventricular (i.c.v.) administration of taurolithocholate (tLCA), a strong TGR5 agonist, and GW4064, a synthetic FXR agonist, on energy metabolism. We determined the effects of chronic i.c.v. infusion of tLCA, GW4064, or vehicle on energy expenditure, body weight and composition as well as tissue specific fatty acid uptake in mice equipped with osmotic minipumps. We found that i.c.v. administration of tLCA (final concentration in cerebrospinal fluid: 1 mu M) increased fat oxidation (tLCA group: 0.083 +/- 0.006 vs control group: 0.036 +/- 0.023 kcal/h, F = 5.46, P = 0.04) and decreased fat mass (after 9 days of tLCA infusion: 1.35 +/- 0.13 vs controls: 1.96 +/- 0.23 g, P = 0.03). These changes were associated with enhanced uptake of triglyceride-derived fatty acids by brown adipose tissue and with browning of subcutaneous white adipose tissue. I.c.v. administration of GW4064 (final concentration in cerebrospinal fluid: 10 mu M) did not affect energy metabolism, body composition nor bile acid levels, negating a role of FXR in the central nervous system in metabolic control. In conclusion, bile acids such as tLCA may exert metabolic effects on fat metabolism via the brain

AB - Bile acids can function in the postprandial state as circulating signaling molecules in the regulation of glucose and lipid metabolism via the transmembrane receptor TGR5 and nuclear receptor FXR. Both receptors are present in the central nervous system, but their function in the brain is unclear. Therefore, we investigated the effects of intracerebroventricular (i.c.v.) administration of taurolithocholate (tLCA), a strong TGR5 agonist, and GW4064, a synthetic FXR agonist, on energy metabolism. We determined the effects of chronic i.c.v. infusion of tLCA, GW4064, or vehicle on energy expenditure, body weight and composition as well as tissue specific fatty acid uptake in mice equipped with osmotic minipumps. We found that i.c.v. administration of tLCA (final concentration in cerebrospinal fluid: 1 mu M) increased fat oxidation (tLCA group: 0.083 +/- 0.006 vs control group: 0.036 +/- 0.023 kcal/h, F = 5.46, P = 0.04) and decreased fat mass (after 9 days of tLCA infusion: 1.35 +/- 0.13 vs controls: 1.96 +/- 0.23 g, P = 0.03). These changes were associated with enhanced uptake of triglyceride-derived fatty acids by brown adipose tissue and with browning of subcutaneous white adipose tissue. I.c.v. administration of GW4064 (final concentration in cerebrospinal fluid: 10 mu M) did not affect energy metabolism, body composition nor bile acid levels, negating a role of FXR in the central nervous system in metabolic control. In conclusion, bile acids such as tLCA may exert metabolic effects on fat metabolism via the brain

U2 - 10.1530/JOE-17-0503

DO - 10.1530/JOE-17-0503

M3 - Article

C2 - 29233934

VL - 236

SP - 85

EP - 97

JO - Journal of endocrinology

JF - Journal of endocrinology

SN - 0022-0795

IS - 2

ER -

ID: 4437835